1. CS014 is a novel HDAC inhibitor regulating the platelet activity, fibrinolysis and clot stability for prevention of thrombosis without increased risk of bleeding. (3rd October 2022) Authors: Holinstat, M; Adili, R; Stanger, L; Hoang, T; Lambert, S; Rhoads, N; Dahlof, B; Bergh, N Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗